Pharmacy Practice Notice
Transition to Nicovape® Q2 System Complete
In June 2024, Liber Pharmaceuticals launched its updated Nicovape® Q system, the NVQ2, in compliance with changes to TGO 110, the standard for therapeutic vaping goods. The revised TGO 110 improved safety and quality requirements for NVPs, and limited permitted flavours for therapeutic vaping to mint, menthol and tobacco.
Whilst the existing Nicovape® Q A1 range meets the requirements of the new TGO 110, and continued access was important to ensure continued supply to existing patients, Liber has completed a six-month transition process for Nicovape® Q A1 users to the new NVQ2 product and now wishes to remove the Nicovape® Q A1 from circulation.
From January 14th, 2025, Liber Pharmaceuticals has instructed all wholesalers to cease ongoing supply of the following affected Nicovape® Q A1 SKUs:
| SKU | EAN |
|---|---|
| Nicovape® Q Nicotine 59 mg/mL CLASSIC FLV Cartridge 2 Twin Pack | 9358551000088 |
| Nicovape® Q Nicotine 59 mg/mL COOLMINT FLV Cartridge 2 Twin Pack | 9358551000149 |
| Nicovape® Q SD Nicotine 35 mg/mL CLASSIC FLV Cartridge 2 Twin Pack | 9358551000361 |
| Nicovape® Q SD Nicotine 35 mg/mL COOLMINT FLV Cartridge 2 Twin Pack | 9358551000385 |
| Nicovape® Q SD Nicotine 20 mg/mL CLASSIC FLV Cartridge 2 Twin Pack | 9358551000491 |
| Nicovape® Q SD Nicotine 20 mg/mL COOLMINT FLV Cartridge 2 Twin Pack | 9358551000514 |
| Nicovape® Q A1 Device Kit | 9358551000101 |
These SKUs will no longer be available to your banner network pharmacies to order via their preferred CSO Pharmaceutical Wholesaler.
For all existing Nicovape® Q A1 stock that is still in your pharmacy’s possession, and to ensure an orderly removal of all remaining Nicovape® Q A1 stock, please lodge a claim via the button below.
Request a pharmacy pack
Liber:Onboard
Onboard your pharmacy with Liber’s medical liaison team today
Liber:Activate
Establish your local GPs as activated authorised prescribers
Important links
Therapeutic Goods Administration
Pharmaceutical Society of Australia
References
- PSA Professional Practice Standard 1: https://www.psa.org.au/practice-support-industry/pps/
© 2024 Liber Pharmaceuticals Ltd. All content
iNRT Healthcare is operated by Liber Pharmaceuticals for the purpose of furthering healthcare education regarding Nicotine Vaping Products (NVPs) within the Australian medical framework. Liber has no affiliation with the tobacco industry, their affiliates, or any organisations or individuals engaged in lobbying on their behalf.
This site is intended for use only by Australian-registered healthcare professionals with an interest in smoking cessation. It is not intended for use by consumers.
This content is gated for Australian healthcare professionals only
This website is a source of educational content for Australian-registered healthcare professionals only. You must not use the content for any other purpose. If you are a patient seeking medical advice please see your healthcare professional.
By accessing this website you are agreeing that you are an Australian-registered healthcare professional with a current AHPRA registration and are entitled to access this content. Your use of this content is also subject to our Terms of Use and Privacy Policy.